1.Naiki H, Sekijima Y, Ueda M, Ohashi K, Hoshii Y, Shimoda M, Ando Y: Human amyloidosis, still intractable but becoming curable: The essential role of pathological diagnosis in the selection of type-specific therapeutics. Pathol Int, 70: 191-198, 2020.

2.Koto S, Umeda M, Kawano H, Endo Y, Shimizu T, Koga T, Ichinose K, Nakamura H, Mukaino A, Higuchi O, Nakane S, Kawakami A: Behçet’s Disease with Severe Autonomic Disorders Developing after Herpes Zoster. Intern Med, 59: 1099-1104, 2020.

3.Ogata H, Isobe N, Zhang X, Yamasaki R, Fujii T, Machida A, Morimoto N, Kaida K, Masuda T, Ando Y, Kuwahara M, Kusunoki S, Nakamura Y, Matsushita T, Kira JI: Unique HLA haplotype associations in IgG4 anti-neurofascin 155 antibody-positive chronic inflammatory demyelinating polyneuropathy. J Neuroimmunol, 339: 577139, 2020.

4.González-Duarte A, Berk JL, Quan D, Mauermann ML, Schmidt HH, Polydefkis M, Waddington-Cruz M, Ueda M, Conceição IM, Kristen AV, Coelho T, Cauquil CA, Tard C, Merkel M, Aldinc E, Chen J, Sweetser MT, Wang JJ, Adams D: Correction to: Analysis of autonomic outcomes in APOLLO, a phase III trial of the RNAi therapeutic patisiran in patients with hereditary transthyretin-mediated amyloidosis. J Neurol, 267: 713-714, 2020.

5.Nakane S, Mukaino A, Higuchi O, Yasuhiro M, Takamatsu K, Yamakawa M, Watari M, Tawara N, Nakahara KI, Kawakami A, Matsuo H, Ando Y: A comprehensive analysis of the clinical characteristics and laboratory features in 179 patients with autoimmune autonomic ganglionopathy. J Autoimmun, 108: 102403, 2020.

6.Murakami T, Noguchi K, Hachiya N, Kametani F, Tasaki M, Nakaba S, Sassa Y, Yamashita T, Obayashi K, Ando Y, Hamamura M, Kanno T, Kawasako K: Needle-shaped amyloid deposition in rat mammary gland: evidence of a novel amyloid fibril protein. Amyloid, 27: 25-35, 2020.

7.Nakane S, Umeda M, Kawashiri SY, Mukaino A, Ichinose K, Higuchi O, Maeda Y, Nakamura H, Matsuo H, Kawakami A: Detecting gastrointestinal manifestations in patients with systemic sclerosis using anti-gAChR antibodies. Arthritis Res Ther, 22: 32, 2020.

8.Imamura M, Mukaino A, Takamatsu K, Tsuboi H, Higuchi O, Nakamura H, Abe S, Ando Y, Matsuo H, Nakamura T, Sumida T, Kawakami A, Nakane S: Ganglionic Acetylcholine Receptor Antibodies and Autonomic Dysfunction in Autoimmune Rheumatic Diseases. Int J Mol Sci, 21: pii:E1332, 2020.

9.Ochi Y, Kubo T, Nakashima Y, Baba Y, Hirota T, Yamasaki N, Yamashita T, Ueda M, Ando Y, Kitaoka H: Integrated diagnostic approach to wild-type transthyretin cardiac amyloidosis with the use of high-sensitivity cardiac troponin T measurement and ^99mTc-pyrophosphate scintigraphy. J Cardiol, 75: 12-19, 2020.

10.Nakahara K, Nakane S, Kitajima M, Masuda-Narita T, Matsuo H, Ando Y: Diagnostic accuracy of MRI parameters in pure akinesia with gait freezing. J Neurol, 267: 752-759, 2020.

11.González-Duarte A, Berk JL, Quan D, Mauermann ML, Schmidt HH, Polydefkis M, Waddington-Cruz M, Ueda M, Conceição IM, Kristen AV, Coelho T, Cauquil CA, Tard C, Merkel M, Aldinc E, Chen J, Sweetser MT, Wang JJ, Adams D: Analysis of autonomic outcomes in APOLLO, a phase III trial of the RNAi therapeutic patisiran in patients with hereditary transthyretin-mediated amyloidosis. J Neurol, 267: 703-712, 2020.

12.Izumi Y, Hamaguchi A, Miura R, Nakagawa T, Nakagawa M, Saida K, Miyake N, Nagayoshi Y, Kakizoe Y, Miyoshi T, Kohda Y, Misumi Y, Matsumoto N, Ando Y, Mukoyama M: Autosomal dominant Alport syndrome due to a COL4A4 mutation with an additional ESPN variant detected by whole-exome analysis. CEN case Rep, 9: 59-64, 2020.

13.Kinoshita K, Ishizaki Y, Yamamoto H, Sonoda M, Yonemoto K, Kira R, Sanefuji M, Ueda A, Matsui H, Ando Y, Sakai Y, Ohga S: De novo p.G696S mutation in COL4A1 causes intracranial calcification and late-onset cerebral hemorrhage: A case report and review of the literature. Eur J Med Genet, 63: 103825, 202..

14.Seki M, Uruha A, Ohnuki Y, Kamada S, Noda T, Onda A, Ohira M, Isami A, Hiramatsu S, Hibino M, Nakane S, Noda S, Yutani S, Hanazono A, Yaguchi H, Takao M, Shiina T, Katsuno M, Nakahara J, Matsubara S, Nishino I, Suzuki S: Inflammatory myopathy associated with PD-1 inhibitors. J Autoimmun, 100:105-113, 201..

15.Endo J, Sano M, Izumiya Y, Tsujita K, Nakamura K, Tahara N, Kuwahara K, Inomata T, Ueda M, Sekijima Y, Ando Y, Tsutsui H, Isobe M, Fukuda K: A Statement on the Appropriate Administration of Tafamidis in Patients With Transthyretin Cardiac Amyloidosis. Circ J, 84: 15-17, 2019.

16.Inoue Y, Ueda M, Masuda T, Misumi Y, Yamashita T, Ando Y: Memantine, a Noncompetitive N-Methyl-D-Aspartate Receptor Antagonist, Attenuates Cerebral Amyloid Angiopathy by Increasing Insulin-Degrading Enzyme Expression. Mol Neurobiol, 56: 8573-8588, 2019.

17.Suda S, Iguchi Y, Fujimoto S, Yagita Y, Kono Y, Ueda M, Todo K, Kono T, Mizunari T, Yamazaki M, Kanzawa T, Okubo S, Kondo K, Nakajima N, Inoue T, Iwanaga T, Nakajima M, Imafuku I, Shibazaki K, Mishina M, Adachi K, Nomura K, Nakajima M, Yaguchi H, Okamoto S, Osaki M, Terasawa Y, Nagao T, Kimura K: Multicenter Prospective Analysis of Stroke Patients Taking Oral Anticoagulants: The PASTA Registry – Study Design and Characteristics. J Stroke Cerebrovasc Dis, 28: 104456, 2019.

18.Yamashita S, Kimura E, Zhang Z, Tawara N, Hara K, Yoshimura a, Takashima H, Ando Y: Muscle pathology of hereditary motor and sensory neuropathy with proximal dominant involvement with TFG mutation. Muscle Nerve, 60: 739-744, 2019.

19.Ogata H, Zhang X, Yamasaki R, Fujii T, Machida A, Morimoto N, Kaida K, Masuda T, Ando Y, Kuwahara M, Kusunoki S, Nakamura Y, Matsushita T, Isobe N, Kira JI: Intrathecal cytokine profile in neuropathy with anti-neurofascin 155 antibody. Ann Clin Transl Neurol, 6: 2304-2316, 2019.

20.Azuma M, Hirai T, Nakaura T, Kitajima M, Yamashita S, Hashimoto M, Yamada K, Uetani H, Yamashita Y, Wang Y: Combining quantitative susceptibility mapping to the morphometric index in differentiating between progressive supranuclear palsy and Parkinson’s disease. J Neurol Sci, 406: 116443, 2019.

21.Ikeda T, Ikenoshita S, Sakamoto F, Shiraishi S, Nakahara K, Masuda T, Yamashita S: Is ¹²³I-MIBG Scintigraphy Beneficial or Excessive for the Diagnosis of Parkinson’s Disease in the Early Phase? Neurodegener Dis, 19: 88-95, 2019.

22.Doki T, Yamashita S, Wei FY, Hara K, YCoamamoto T, Zhang Z, Zhang X, Tawara N, Hino H, Uyama E, Kurishige T, Maruyama H, Tomizawa K, Ando Y: Mitochondrial localization of PABPN1 in oculopharyngeal muscular dystrophy. Lab Invest, 99: 1728-1740, 2019.

23.Miura M, Shindo S, Nakajima M, Namitome S, Wada K, Nagao Y, Sugimura Y, Terasaki T, Ando Y: Stent Retriever-Assisted Continuous Aspiration for Distal Intracranial Vessel Embolectomy: The Distal Combined Technique. World Neurosurg, 131: e495-e502, 2019.

24.Misumi Y, Ueda M, Masuda T, Tsuda Y, Nomura T, Okada M, Inoue Y, Tasaki M, Obayashi K, Yamashita T, Ando Y: Characteristics of acquired transthyretin amyloidosis: A case series and review of the literature. Neurology, 93: e1587-e1596, 2019.

25.Zhang X, Yamashita S, Hara K, Doki T, Tawara N, Ikeda T, Misumi Y, Zhang Z, Matsuo Y, Nagai M, Kurashige T, Maruyama H, Ando Y: Mutant MATR3 mouse model to explain multisystem proteinopathy. J Pathol, 249: 182-192, 2019.

26.Yamashita T, Ueda M, Nomura T, Okazaki T, Okada M, Tsuda Y, Inoue Y, Masuda T, Misumi Y, Takamatsu K, Obayashi K, Inomata Y, Hibi T, Ando Y: Natural history and long-term effects of variant protein reduction in non-V30M ATTR amyloidosis. Neurology, 93: 714-716, 2019.

27.Nakase T, Yamashita T, Matsuo Y, Nomura T, Sasada K, Masuda T, Misumi Y, Takamatsu K, Oda S, Furukawa Y, Obayashi K, Matsui H, Ando Y, Ueda M: Hereditary ATTR Amyloidosis with Cardiomyopathy Caused by the Novel Variant Transthyretin Y114S (p.Y134S). Intern Med, 58: 2695-2698, 2019.

28.Hanna MG, Badrising UA, Benveniste O, Lloyd TE, Needham M, Chinoy H, Aoki M, Machado PM, Liang C, Reardon KA, de Visser M, Ascherman DP, Barohn RJ, Dimachkie MM, Miller JAL, Kissel JT, Oskarsson B, Joyce NC, Van den Bergh P, Baets J, De Bleeckeer JL, Karam C, David WS, Mirabella M, Nations SP, Jung HH, Pegoraro E, Maggi L, Rodolico C, Filosto M, Shaibani AI, Sivakumar K, Goya NA, Mori-Yoshimura M, Yamashita S, Suzuki N, Katsuno M, Murata K, Nodera H, Nishino I, Romano CD, Williams VSL, Vissing J, Auberson LZ, Wu M, de Vera A, Papanicolaou DA, Amato AA, RESILIENT Study Group: Safety and efficacy of intravenous bimagrumab in inclusion body myositis (RESILIENT): a randomised, double-blind, placebo-controlled phase 2b trial. Lancet Neurol, 18:834-844, 2019.

29.Yamashita S, Matsuo Y, Tawara N, Hara K, Yamamoto M, Nishikami T, Kawakami K, Zhang X, Zhang Z, Doki T, Ando Y: CYLD dysregulation in pathogenesis of sporadic inclusion body myositis. Sci Rep, 9: 11606, 2019.

30.Takamiya M, Takahashi Y, Morimoto M, Morimoto N, Yamashita S, Abe K: Effect of intravenous immunoglobulin therapy on anti-NT5C1A antibody-positive inclusion body myositis after successful treatment of hepatitis C: A case report. eNeurologicalSci, 16: 100204, 2019.

31.Hamanaka K, Miyatake S, Koshimizu E, Tsurusaki Y, Mitsuhashi S, Iwama K, Alkanaq AN, Fujita A, Imagawa E, Uchiyama Y, Tawara N, Ando Y, Misumi Y, Okubo M, Nakashima M, Mizuguchi T, Takata A, Miyake N, Saitsu H, Iida A, Nishino I, Matsumoto N: RNA sequencing solved the most common but unrecognized NEB pathogenic variant in Japanese nemaline myopathy. Genet Med, 21: 1629-1638, 2019.

32.Ueda M, Okada M, Mizuguchi M, Kluve-Beckerman B, Kanenawa K, Isoguchi A, Misumi Y, Tasaki M, Ueda A, Kanai A, Sasaki R, Masuda T, Inoue Y, Nomura T, Shinriki S, Shuto T, Kai H, Yamashita T, Matsui H, Benson MD, Ando Y: A cell-based high-throughput screening method to directly examine transthyretin amyloid fibril formation at neutral pH. J Biol Chem, 294: 11259-11275, 2019.

33.Ando Y, Ueda M, Jono H: Introduction. Amyloid, 26: 1-3, 2019.

34.Conceição I, Damy T, Romero M, Galán L, Attarian S, Luigetti M, Sadeh M, Sarafov S, Tournev I, Ueda M: Early diagnosis of ATTR amyloidosis through targeted follow-up of identified carriers of TTR gene mutations. Amyloid, 26: 3-9, 2019.

35.Yamashita T, Ueda M, Misawa S, Inoue Y, Masuda T, Misumi Y, Takamatsu K, Obayashi K, Kuwabara S, Ando Y: Changes in nerve excitability indices in hereditary transthyretin amyloidosis. Amyloid, 26: 9-10, 2019.

36.Yamashita T, Ohnishi K, Ueda M, Masuda T, Inoue Y, Misumi Y, Ueda A, Obayashi K, Takeya M, Ando Y: Transthyretin amyloid-related cerebral angiitis after liver transplantation. Amyloid, 26: 11-12, 2019.

37.Obayashi K, Masuda T, Tasaki M, Ando Y, Ueda M: Serum diacron-reactive oxygen metabolites (d-ROMs) and biological antioxidant potential (BAP) in patients with ATTR-PN. Amyloid, 26: 65, 2019.

38.Obayashi K, Masuda T, Tasaki M, Ando Y, Ueda M: Evaluation of myoelectrical activities of descending colon by electrointestinogram in patients with ATTRm amyloidosis. Amyloid, 26: 66, 2019.

39.Isoguchi A, Ueda M, Kanenawa K, Masuda T, Misumi Y, Yamashita T, Obayashi K, Ando Y: A novel transgenic mouse model expressing mutant TTR gene causing oculoleptomeningeal type of ATTRm amyloidosis. Amyloid, 26: 69, 2019.

40.Masuda T, Ueda M, Misumi Y, Nomura T, Inoue Y, Isoguchi A, Kanenawa K, Tasaki M, Yamashita T, Sonoda Y, Obayashi K, Ando Y: Reduced intraepidermal nerve fibre density in patients with hereditary transthyretin amyloidosis. Amyloid, 26: 79-80, 2019.

41.Nakajima M, Takeuchi Y, Nagao Y, Masuda T, Yamashita T, Yonehara T, Terasaki T, Ando Y: Comparison of clinical features in transient focal neurological episodes between hereditary transthyretin type and Aβ type cerebral amyloid angiopathy. Amyloid, 26: 81-82, 2019.

42.Oda S, Nakaura T, Utsunomiya D, Hirakawa K, Takashio S, Izumiya Y, Tsujita K, Kawano Y, Okuno Y, Hata H, Matsuoka M, Yamashita T, Ueda M, Ando Y, Yamashita Y: Clinical potential of dual-energy cardiac CT in cardiac amyloidosis. Amyloid, 26: 91-92. 2019.

43.Okuda Y, Yamada T, Ueda M, Ando Y: Nationwide survey of 199 patients with reactive amyloid a amyloidosis in Japan. Amyloid, 26: 129, 2019.

44.Yamaguchi I, Kokubo Y, Yamashita T, Ueda M, Okoshi T, Matsumine A, Ando Y, Naiki H: Class I small leucine-rich proteoglycans (SLRPs) colocalise with the Aβ2M amyloid deposits: implications for the roles of SLRP core proteins in the pathogenesis of dialysis-related amyloidosis. Amyloid, 26: 140-141, 2019.

45.Nakahara K, Nakane S, Ando Y: Correlation of heart rate variability analysis and MIBG myocardial scintigraphy in patients with Parkinson’s disease. Amyloid, 26: 146-147, 2019.

46.Nagase T, Iwaya K, Zako T, Odaka T, Kogure K, Nemoto Y, Misumi Y, Noritake M, Ando Y, Katsura Y: Clinical and MRI characteristics and follow-up studies of insulin-derived amyloidosis. Amyloid, 26: 156-157, 2019.

47.Kanenawa K, Ueda M, Isoguchi A, Nomura T, Tsuda Y, Masuda T, Misumi Y, Yamashita T, Ando Y: Histopathological and biochemical analyses of prostate corpora amylacea. Amyloid, 26: 160-161, 2019.

48.Marume K, Takashio S, Nishi M, Hirakawa K, Yamamoto M, Hanatani S, Oda S, Utsunomiya D, Shiraishi S, Ueda M, Yamashita T, Sakamoto K, Yamamoto E, Kaikita K, Izumiya Y, Yamashita Y, Ando Y, Tsujita K: Combination of Commonly Examined Parameters Is a Useful Predictor of Positive ^{99 m}Tc-Labeled Pyrophosphate Scintigraphy Findings in Elderly Patients With Suspected Transthyretin Cardiac Amyloidosis. Circ J, 83: 1698-1708, 2019.

49.Ueda M, Yamashita T, Misumi Y, Masuda T, Ando Y: Reader response: Natural history and survival in stage 1 Val30Met transthyretin familial amyloid polyneuropathy. Neurology, 93: 228-229, 2019.

50.Tasaki M, Milani P, Foli A, Verga L, Obici L, Basset M, Bozzola M, Ferraro G, Nuvolone M, Morbini P, Capello G, Ueda M, Obayashi K, Paulli M, Ando Y, Merlini G, Palladini G, Lavatelli F: Simple, reliable detection of amyloid in fat aspirates using the fluorescent dye FSB: prospective study in 206 patients. Blood, 134: 320-323, 2019.

51.Kumai Y, Miyamoto T, Matsubara K, Samejima Y, Yamashita S, Ando Y, Orita Y: Assessment of oropharyngeal swallowing dysfunction in myasthenia gravis patients presenting with difficulty in swallowing. Auris Nasus Larynx, 46: 390-396, 2019.

52.Suzuki N, Mori-Yoshimura M, Yamashita S, Nakano S, Murata KY, Mori M, Inamori Y, Matsui N, Kimura E, Kusaka H, Kondo T, Ito H, Higuchi I, Hashiguchi A, Nodera H, Kaji R, Tateyama M, Izumi R, Ono H, Kato M, Warita H, Takahashi T, Nishino I, Aoki M: The updated retrospective questionnaire study of sporadic inclusion body myositis in Japan. Orphanet J Rare Dis, 14: 155, 2019.

53.Sekijima Y, Ueda M, Koike H, Misawa S, Ishii T, Ando Y: Correction to: Diagnosis and management of transthyretin familial amyloid polyneuropathy in Japan: red-flag symptom clusters and treatment algorithm. Orphanet J Rare Dis, 14: 111, 2019.

54.Nomura T, Ueda M, Tasaki M, Misumi Y, Masuda T, Inoue Y, Tsuda Y, Okada M, Okazaki T, Kanenawa K, Isoguchi A, Nakamura M, Obayashi K, Shinriki S, Matsui H, Yamashita T, Ando Y: New simple and quick method to analyze serum variant transthyretins: direct MALDI method for the screening of hereditary transthyretin amyloidosis. Orphanet J Rare Dis, 14: 116, 2019.

55.Inoue M, Ueda M, Higashi T, Anno T, Fujisawa K, Motoyama K, Mizuguchi M, Ando Y, Jono H, Arima H: Therapeutic Potential of Polyamidoamine Dendrimer for Amyloidogenic Transthyretin Amyloidosis. ACS Chem Neurosci, 10: 2584-2590, 2019.

56.Takeuchi Y, Nakahara K, Nakajima M, Inoue Y, Matsumura R, Yamaguchi M, Katabuchi H, Ando Y: A 23-Year-Old Woman with Sudden-Onset Blindness of the Right Eye. J Stroke Cerebrovasc Dis, 28: e12-e13, 2019.

57.Tasaki M, Ueda M, Hoshii Y, Mizukami M, Matsumoto S, Nakamura M, Yamashita T, Ueda A, Misumi Y, Masuda T, Inoue Y, Torikai T, Nomura T, Tsuda Y, Kanenawa K, Isoguchi A, Okada M, Matsui H, Obayashi K, Ando Y: A novel age-related venous amyloidosis derived from EGF-containing fibulin-like extracellular matrix protein 1. J Pathol, 247: 444-455, 2019.